Mapi Pharma
Clinical-stage pharmaceutical company engaged in the development of improved extended-release versions of existing, commercially successful products.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
$10.0m | Post IPO Equity | ||
* | $10.0m | Post IPO Equity | |
* | $10.0m | Post IPO Equity | |
* | $2.5m | Grant | |
Total Funding | €2.3m |
Recent News about Mapi Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.